Dopamine Transporter Imaging of Subthalamic Nucleus Deep Brain Stimulation in Patients with Parkinson's Disease

梁晋川,胡小吾,周晓平,左传涛,吴平,陈剑春,郝斌,吴曦,陈鑫
DOI: https://doi.org/10.3760/cma.j.issn.1001-2346.2013.12.004
2013-01-01
Abstract:Objective To determine the relationship between the change of dopamine transporter (DAT) and clinical efficacy of the subthalamic nucleus deep brain stimulation (STN-DBS)for Parkinson's Disease (PD) patients.Methods Between February 2011 and July 2011,13 PD patients received 11 C-β-CFT-PET/CT brain scan in a week before and 6 months after the STN-DBS treatment.Results The DAT in corpus striatum significantly decreased in all the patients and significantly decreased after surgery (P < 0.05).The preoperative UPDRS Ⅲ score with medication 'on 'was significant negative correlation with the preoperative DAT level in caudatum and putamen.The R2 were 0.522,0.380,0.419 respectively.The negative correlation was also found between postoperative UPDRS Ⅲ score with the postoperative DAT level when simulation was 'on'.The R2were 0.402,0.350,0.307 respectively.The most correlated factor was the DAT level in caudatum by mult-variable linear return analysis.Conclusions It was not found that the dopamine neuron was protected by STN-DBS.DAT level may be an objective indicator to estimate the efficacy of anti-parkinsonian therapy.
What problem does this paper attempt to address?